Cancer drug's stumbles prompt calls to rethink how immune therapies are tested

Cancer drug's stumbles prompt calls to rethink how immune therapies are testedCancer drug's stumbles prompt calls to rethink how immune therapies are tested, Published online: 19 November 2018; doi:10.1038/d41586-018-07445-3Some researchers say that clinical trials of drugs to bolster the body's immune system are moving too fast.
Source: Nature AOP - Category: Research Authors: Source Type: research